Dennis Langer, Director at MYRIAD GENETICS INC (MYGN), sold 49,631 shares at $38.90 ($2.0M) on 2018-06-01, disclosed to the SEC on 2018-06-05.
Open-market sale of $2.0M MYGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.90 | 30,000 | $1.2M | 59.8% |
| 2 | $39.90 | 8,404 | $335K | 17.2% |
| 3 | $39.90 | 10,000 | $399K | 20.5% |
| 4 | $39.90 | 1,227 | $49K | 2.5% |
| Total | $39.30 avg | 49,631 | $2.0M | 100% |
| Filing → |
| MYGN | SELL | 2021-08-05 | $1.0M | — | Filing → |
| DRNA | SELL | 2018-08-17 | $613K | — | Filing → |
| MYGN | SELL | 2018-06-08 | $1.6M | — | Filing → |